of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: A matched cohort analysis of BSRBR-RA registry

Objectives. Previous ecological data suggest a decline in the need for joint replacements in RA patients following the introduction of TNF inhibitor (TNFi) therapy, although patient-level data are lacking. Our primary aim was to estimate the association between TNFi use and subsequent incidence of total hip replacement (THR) and total knee replacement. Methods. A propensity score matched cohort was analysed using the British Society for Rheumatology Biologics Registry (2001 (cid:2) 2016) for RA data. Propensity score estimates were used to match TNFi users to similar conventional synthetic DMARD users (with replacement) using a 1:1 ratio. Weighted multivariable Cox regression was used to estimate the impact of TNFi on study outcomes. Effect modification by baseline age and disease severity were investigated. Joint replacement at other sites was also analysed. An instrumental variable sensitivity analysis was also performed. Results. The matched analysis contained a total of 19 116 patient records. Overall, there was no significant association between TNFi use vs conventional synthetic DMARD on rates of THR (hazard ratios = 0.86 [95% CI: 0.60, 1.22]) although there was significant effect modification by age ( P < 0 .001). TNFi was associated with a reduction in THR among those > 60years old (hazard ratio = 0.60 [CI: 0.41, 0.87]) but not in younger patients. No significant associations were found for total knee replacement or other joint replacement. Conclusion. Overall, no association was found between the use of TNFi and subsequent incidence of joint replacement. However, TNFi was associated with a 40% relative reduction in THR rates among older patients.

[1]  A. Odgaard,et al.  SAT0081 Changes in incidence of shoulder, elbow, wrist and finger replacement surgery among rheumatoid arthritis patients following the introduction of biological dmards: an interrupted time series analysis using danish health care registers , 2018, Saturday, 16 JUNE 2018.

[2]  A. Silman,et al.  The impact of rheumatoid arthritis on the risk of adverse events following joint replacement: a real-world cohort study , 2018, Clinical epidemiology.

[3]  A. Silman,et al.  Trends and determinants of length of stay and hospital reimbursement following knee and hip replacement: evidence from linked primary care and NHS hospital records from 1997 to 2014 , 2018, BMJ Open.

[4]  A. Odgaard,et al.  Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using nationwide Danish healthcare registers , 2017, Annals of the rheumatic diseases.

[5]  A. Silman,et al.  Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: An interrupted time-series analysis. , 2017, Seminars in arthritis and rheumatism.

[6]  J. O'dell,et al.  Therapies for Active Rheumatoid Arthritis after Methotrexate Failure , 2017 .

[7]  G. Collins,et al.  Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance , 2017, BMC Medical Research Methodology.

[8]  Ashkan Ertefaie,et al.  A tutorial on the use of instrumental variables in pharmacoepidemiology , 2017, Pharmacoepidemiology and drug safety.

[9]  T. V. Vliet Vlieland,et al.  Indication criteria for total hip or knee arthroplasty in osteoarthritis: a state-of-the-science overview , 2016, BMC Musculoskeletal Disorders.

[10]  A. Mebazaa,et al.  Propensity score estimators for the average treatment effect and the average treatment effect on the treated may yield very different estimates , 2016, Statistical methods in medical research.

[11]  Y. Kawahito.  [Guidelines for the management of rheumatoid arthritis]. , 2016, Nihon rinsho. Japanese journal of clinical medicine.

[12]  S. Norton,et al.  Association between rheumatoid arthritis disease activity, progression of functional limitation and long-term risk of orthopaedic surgery: combined analysis of two prospective cohorts supports EULAR treat to target DAS thresholds , 2016, Annals of the rheumatic diseases.

[13]  L. Havelin,et al.  Reduction in orthopaedic surgery in patients with rheumatoid arthritis: a Norwegian register-based study , 2016, Scandinavian journal of rheumatology.

[14]  G. Jürgens,et al.  Combination Therapy With and Without Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Trials , 2015, Arthritis care & research.

[15]  O. FitzGerald,et al.  Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010). , 2015, Rheumatology.

[16]  L. Mandl,et al.  US Trends in Rates of Arthroplasty for Inflammatory Arthritis Including Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritis , 2014, Arthritis & rheumatology.

[17]  S. Norton,et al.  Hand and Foot Surgery Rates in Rheumatoid Arthritis Have Declined From 1986 to 2011, but Large‐Joint Replacement Rates Remain Unchanged: Results From Two UK Inception Cohorts , 2014, Arthritis & rheumatology.

[18]  L. Virta,et al.  The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy , 2013, Acta orthopaedica.

[19]  Y. Konttinen,et al.  Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study. , 2013, Seminars in arthritis and rheumatism.

[20]  Kristian Thorlund,et al.  Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings , 2012, Annals of the rheumatic diseases.

[21]  G. Hawker,et al.  A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. , 2012, Arthritis and rheumatism.

[22]  Georg Schett,et al.  Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment , 2012, Nature Reviews Rheumatology.

[23]  Jeffrey R Curtis,et al.  A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. , 2012, Arthritis and rheumatism.

[24]  S. Gabriel,et al.  Cardiomyopathy Caused by Longterm Treatment with Chloroquine: A Rare Disease or a Rare Diagnosis? , 2012, The Journal of Rheumatology.

[25]  P. Ravaud,et al.  Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. , 2012, Archives of internal medicine.

[26]  D. Scott.  Biologics‐Based Therapy for the Treatment of Rheumatoid Arthritis , 2012, Clinical pharmacology and therapeutics.

[27]  J. Singh,et al.  Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. , 2011, Clinical therapeutics.

[28]  G. Garellick,et al.  Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south Sweden , 2011, Arthritis research & therapy.

[29]  G. Jürgens,et al.  Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons. , 2010, Arthritis and rheumatism.

[30]  E. Keystone,et al.  Efficacy of initial methotrexate monotherapy versus combination therapy with a biological agent in early rheumatoid arthritis: a meta-analysis of clinical and radiographic remission , 2010, Annals of the rheumatic diseases.

[31]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[32]  M. Ward,et al.  Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983–2007 , 2009, Annals of the rheumatic diseases.

[33]  P. Austin.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples , 2009, Statistics in medicine.

[34]  Peter C. Austin,et al.  Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research , 2009, Commun. Stat. Simul. Comput..

[35]  Zoe Stableford,et al.  British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). , 2006, Rheumatology.

[36]  Peter C Austin,et al.  The performance of different propensity-score methods for estimating relative risks. , 2008, Journal of clinical epidemiology.

[37]  M Alan Brookhart,et al.  Evaluating Short-Term Drug Effects Using a Physician-Specific Prescribing Preference as an Instrumental Variable , 2006, Epidemiology.

[38]  N. Goodson,et al.  British Society for Rheumatology and british health professionals in Rheumatology guideline for the management of rheumatoid arthritis (the first two years). , 2006, Rheumatology.

[39]  R. Nelissen.  The impact of total joint replacement in rheumatoid arthritis. , 2003, Best practice & research. Clinical rheumatology.

[40]  R. Yood,et al.  Guidelines for the management of rheumatoid arthritis: 2002 Update. , 2002, Arthritis and rheumatism.

[41]  A Woolf,et al.  The links between joint damage and disability in rheumatoid arthritis. , 2000, Rheumatology.

[42]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.